Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7ZLR

Crystal structure of SOCS2:ElonginB:ElonginC in complex with compound 13

7ZLR の概要
エントリーDOI10.2210/pdb7zlr/pdb
分子名称Suppressor of cytokine signaling 2, Elongin-B, Elongin-C, ... (5 entities in total)
機能のキーワードe3 ligase, suppressor of cytokine signaling, ligase
由来する生物種Homo sapiens (human)
詳細
タンパク質・核酸の鎖数3
化学式量合計43940.15
構造登録者
Ramachandran, S.,Ciulli, A.,Makukhin, N. (登録日: 2022-04-15, 公開日: 2023-04-26, 最終更新日: 2024-05-01)
主引用文献Ramachandran, S.,Makukhin, N.,Haubrich, K.,Nagala, M.,Forrester, B.,Lynch, D.M.,Casement, R.,Testa, A.,Bruno, E.,Gitto, R.,Ciulli, A.
Structure-based design of a phosphotyrosine-masked covalent ligand targeting the E3 ligase SOCS2.
Nat Commun, 14:6345-6345, 2023
Cited by
PubMed Abstract: The Src homology 2 (SH2) domain recognizes phosphotyrosine (pY) post translational modifications in partner proteins to trigger downstream signaling. Drug discovery efforts targeting the SH2 domains have long been stymied by the poor drug-like properties of phosphate and its mimetics. Here, we use structure-based design to target the SH2 domain of the E3 ligase suppressor of cytokine signaling 2 (SOCS2). Starting from the highly ligand-efficient pY amino acid, a fragment growing approach reveals covalent modification of Cys111 in a co-crystal structure, which we leverage to rationally design a cysteine-directed electrophilic covalent inhibitor MN551. We report the prodrug MN714 containing a pivaloyloxymethyl (POM) protecting group and evidence its cell permeability and capping group unmasking using cellular target engagement and in-cell F NMR spectroscopy. Covalent engagement at Cys111 competitively blocks recruitment of cellular SOCS2 protein to its native substrate. The qualified inhibitors of SOCS2 could find attractive applications as chemical probes to understand the biology of SOCS2 and its CRL5 complex, and as E3 ligase handles in proteolysis targeting chimera (PROTACs) to induce targeted protein degradation.
PubMed: 37816714
DOI: 10.1038/s41467-023-41894-3
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.01 Å)
構造検証レポート
Validation report summary of 7zlr
検証レポート(詳細版)ダウンロードをダウンロード

246905

件を2025-12-31に公開中

PDB statisticsPDBj update infoContact PDBjnumon